DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Puoti M, Foster GR, Wang S. et al.
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis.
J Hepatol 2018;
69: 293-300
We do not assume any responsibility for the contents of the web pages of other providers.